Showing 1–20 of 57 results

Show sidebar

DOTA PEG linkers combine a DOTA chelator with a PEG chain. DOTA binds metal ions like copper, gallium, or lutetium. PEG increases stability and solubility.

In imaging and therapy, these linkers attach to targeting molecules for precise delivery. They also enable radiolabeling for non-invasive imaging.

DOTA PEG linkers improve drug half-life and reduce immunogenicity. They are essential in cancer, neurological, and inflammatory treatments, enhancing both drug delivery and diagnostics.

Cat# Name Structure M.W. Purity Pricing
Bromoacetamido-PEG-DOTA
AP12027Bromoacetamido-PEG5-DOTA787.7≥95% Pricing
DOTA-(t-Butyl)3-PEG-azide
AP11518DOTA-(t-Butyl)3-PEG5-azide861.09≥95% Pricing
DOTA-NHS ESTER
AP15441DOTAM-NHS ester498.53≥90% Pricing
AP13088DOTA-NHS ESTER501.49≥95% Pricing
AP15430DOTA-mono-NHS tris (t-Bu ester)815.8≥94% Pricing
DOTA-PEG-amine
AP12200DOTA-PEG5-amine HCl salt666.77≥95% Pricing
DOTA-PEG-azide
AP11517DOTA-PEG5-azide692.77≥95% Pricing
AP15427Azido-mono-amide-DOTA-tris(t-Bu ester)735.8≥94% Pricing
AP15411DOTA-PEG4-azide hydrochloride750.51≥NMR 1H and HPLC-MS (95+%) Pricing
DOTA-PEG-DBCO
AP15446DO3A-DBCO776.8≥94% Pricing
AP15445Deferoxamine-DBCO848≥94% Pricing
AP11147DOTA-PEG5-C6-DBCO982.14≥95% Pricing
FA-PEG-DOTA
AP13089FA-PEG3-DOTA1002.05≥95% Pricing
AP13135DOTA-PEG(24)-TFP*2TFA1680.81*228.05≥95% Pricing
Other DOTA PEG
AP15418DOTAGA-tetra (t-Bu ester)700.9≥94% Pricing
AP15437NO2A-Butyne354.4≥94% Pricing
AP15420p-NO₂-Bn-Cyclen307.4≥94% Pricing
AP15422DOTAM-mono-acid401.5≥95% Pricing
AP15444DOTAM-bis-acid438.5≥94% Pricing
AP15459NO2A-Butyne-bis (t-Butyl ester)466.6≥94% Pricing
AP15438NO2A-Azide494.8≥94% Pricing
AP15309DOTA(OtBu)3572.73≥95% Pricing
AP15453p-NH2-Bn-NOTA517.4≥94% Pricing
AP13134DOTA-PNP525.51≥95% Pricing
AP15435Maleimido-mono-amide-NOTA539.5≥94% Pricing
AP15447NODAGA-tris(t-Bu ester)543.7≥94% Pricing
AP15450p-SCN-Bn-NOTA559.9≥94% Pricing
AP15457p-NH2-Bn-oxo-DO3A561.5≥94% Pricing
AP15462Labetuzumab govitecan154K≥95% Pricing
AP15439p-NH₂-Bn-PCTA594.5≥94% Pricing
AP15451p-SCN-Bn-oxo-DO3A603.9≥94% Pricing
AP15436DTPA-tetra (t-Bu ester)617.8≥94% Pricing
AP15458p-SCN-Bn-PCTA637≥94% Pricing
AP15452p-NH₂-Bn-DTPA644.3≥94% Pricing
AP15455p-SCN-Bn-DTPA649.9≥94% Pricing
AP15426p-NH₂-Bn-DOTA655.4≥94% Pricing
AP15434Butyne-DOTA683.6≥94% Pricing
AP15424p-NO2-Bn-DOTA685.4≥94% Pricing
AP15432p-SCN-Bn-DOTA687.8≥94% Pricing
AP15433DO3A-Thiol691.6≥94% Pricing
AP15448p-SCN-Bn-TCMC693.5≥94% Pricing
AP154252-Aminoethyl-mono-amide-DOTA-tris(t-Bu ester)695.7≥94% Pricing
AP15460p-SCN-Bn-CHX-A”-DTPA704≥94% Pricing
AP15449Deferoxamine-maleimide711.8≥94% Pricing
AP15440p-SCN-Bn-Deferoxamine752.9≥94% Pricing
AP154564-Aminobutyl-DOTA766.4≥94% Pricing
AP15423Butyne-DOTA-tris(t-butyl ester)769.8≥94% Pricing
AP15454p-NH2-Bn-DTPA-penta (t-Bu ester)779≥94% Pricing
AP15419Maleimido-mono-amide-DOTA786.5≥94% Pricing
AP15442Fmoc-L-Lys-DOTAM788.3≥94% Pricing
AP154314-Aminobutyl-DOTA-tris (t-butyl ester)788.8≥94% Pricing
AP15429Maleimido-mono-amide-DOTA-tris (t-Bu ester)840.8≥94% Pricing
AP15428p-NH₂-Bn-DOTA-tetra(t-Bu ester)848≥94% Pricing
AP15461Maleimido-mono-amide-DTPA857.5≥94% Pricing
AP15443DOTAM-maleimide865.66≥95% Pricing
AP15463p-SCN-Bn-HEHA for Actinium972.6≥94% Pricing
AP15421Fmoc-L-Lys-mono-amide-DOTA-tris(t-Bu ester)1069.1≥94% Pricing

Bulk Inquiry


    DOTA PEG Linkers: Enhancing Targeted Imaging and Therapy Overview: DOTA PEG linkers are essential tools in pharmaceutical research, combining a DOTA chelator with a polyethylene glycol (PEG) chain. The DOTA moiety binds to metal ions like copper, gallium, or lutetium, while PEG enhances stability and solubility. Applications:
    • Targeted Molecular Imaging and Therapy: Conjugating DOTA PEG linkers to targeting molecules (e.g., antibodies or ligands) enables selective delivery of therapeutic agents. The DOTA chelator can also label the conjugate with radioactive isotopes for non-invasive imaging.
    • Novel Therapeutics: Used in developing treatments for cancer, neurological disorders, and inflammatory diseases, DOTA PEG linkers improve pharmacokinetics by extending drug half-life and reducing immunogenicity.
    Benefits:
    • Increased Stability and Solubility: PEG enhances the properties of the conjugate.
    • Enhanced Targeting: Enables precise delivery and imaging of specific cells or tissues.
    In summary, DOTA PEG linkers play a crucial role in advancing targeted therapies and imaging techniques, offering improved drug delivery and diagnostic capabilities. ref: Parry JJ, Kelly TS, Andrews R, Rogers BE. In vitro and in vivo evaluation of 64Cu-labeled DOTA-linker-bombesin(7-14) analogues containing different amino acid linker moieties. Bioconjug Chem. 2007 Jul-Aug;18(4):1110-7. doi: 10.1021/bc0603788. Epub 2007 May 16. PMID: 17503761.